Cancer Mutation Profile in 72 Hours with Simple Blood Test
Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test
Guest Editor, Randall Evans, Ph.D of Biodesix, discusses the recent success of a clinical trial of a diagnostic blood test
Ensures Quality, Safety and Efficiency for Proprietary Technology
Commercially available xMAP® MultiFLEX™ Zika RNA assay, designed by GenArraytion, Inc., detects 6 genetic targets of Zika virus
Alere Inc. presented with Scientists' Choice Award at AACC
Beckman Coulter addresses critical factors for clinical laboratories to move healthcare forward
Highly specific assays allow for detection of minor allele frequencies down to 0.1%
How to manage suspected Zika virus cases in the laboratory
Discover Titertek-Berthold’s range on microplate instrumentation and automation solutions: Read, dispense, wash and stack and more!
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Which product made the most difference to your clinical laboratory in 2015?
News highlights from the SelectScience® clinical community
A selection of some of the latest videos available to our clinical community
GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
An exciting programme has been announced for AACC’s 2016 Annual Meeting in Philadelphia
Studies show droplet volume liquid biopsy detects new tumor mass earlier than current imaging methods and detects more mutations than tissue biopsy